From: Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study
Index | Â |
Clinical background | |
 Age, years | 56 ± 11 |
 Sex, male/female, n | 74/22 |
 BMI, kg/m2 | 27.6 ± 4.2 |
 Abdominal circumference, cm | 94.8 ± 20.7 |
 Smoking, current/others, n | 21/75 |
Sleep parameters | |
 AHI, events/h | 36.5 ± 20.7 |
 CT90, % | 13.1 ± 18 |
 Lowest oxygen saturation, % | 78.9 ± 8.3 |
 3% ODI, events/h | 35.3 ± 20.5 |
 Arousal index, events/h | 34.4 ± 17.8 |
 OSA, mild/moderate/severea, n | 12/31/53 |
Comorbidities | |
 Diabetes mellitus, +/−, n | 26/70 |
 Insulin use, +/−, n | 5/91 |
 Hypertension, +/−, n | 58/38 |
 Hypertension (self-reported), +/−, n | 65/31 |
 Dyslipidemia, +/−, n | 62/34 |
 Albuminuriab, macro/micro/−, n | 2/12/82 |
 Chronic obstructive pulmonary disease, +/−, n | 2/94 |
 Asthma, +/−, n | 4/92 |
 Allergic rhinitis, +/−, n | 16/80 |
Blood/Urine tests | |
 Total cholesterol, mg/dL | 196 ± 34 |
 High-density lipoprotein, mg/dL | 53 ± 15 |
 Low-density lipoprotein, mg/dL | 117 ± 30 |
 Triglycerides, mg/dL | 172 ± 121 |
 Free fatty acids, mg/dL | 490 ± 160 |
 Blood glucose, mg/dL | 101 ± 24 |
 Hemoglobin A1c, % | 6.2 ± 0.9 |
 Insulin, μU/mL | 10.7 ± 10.2 |
 Serum periostin, ng/mL | 67.3 ± 22.8 |
 Urinary albumin–creatinine ratioc, mg/g | 25.4 ± 107.1 |